Meta-analysis informed machine learning: Supporting cytokine storm detection during CAR-T cell Therapy
Authors:
- Alex BogatuABAlex Bogatu
- Magdalena WysockaMWMagdalena Wysocka
- Oskar WysockiOWOskar Wysocki
- Holly ButterworthHBHolly Butterworth
- Manon PillaiMPManon Pillai
- Jennifer AllisonJAJennifer Allison
- Dónal LandersDLDónal Landers
- Elaine KilgourEKElaine Kilgour
- Fiona ThistlethwaiteFTFiona Thistlethwaite
- André FreitasAFAndré Freitas
Open Access
- 25 April 2023
- journal article
- research article
- Published by Elsevier in Journal of Biomedical Informatics
- Vol. 142
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
- HORIZON EUROPE Framework Programme (965397)
- University of Manchester
- Cancer Research UK (CTRQQR-2021/100010)
- Cancer Research UK (C5759/ A27412)
- Horizon 2020 Framework Programme
This publication has 55 references indexed in Scilit:
- Current concepts in the diagnosis and management of cytokine release syndromeBlood, 2014
- Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging TherapiesThe Cancer Journal, 2014
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic LeukemiaScience Translational Medicine, 2014
- Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cellsCancer Letters, 2014
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic LeukemiaScience Translational Medicine, 2013
- Dynamics of a Cytokine StormPLOS ONE, 2012
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid LeukemiaNew England Journal of Medicine, 2011
- T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced LeukemiaScience Translational Medicine, 2011
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010